Family Medicine · Bakersfield, CA
NPI
1972537736
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2201 Mount Vernon Ave, Suite 211 A
Bakersfield, CA, 93306
Phone (661) 215-4948
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
7,052 services
Medicare patients, 2024
146
Average age 69
Drug cost, 2024
$2.3M
15,749 prescriptions
Company payments, 2025
$2,326
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mansukh R Ghadiya was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 2,069 times for 141 patients. In total Mansukh R Ghadiya billed 7,052 services in 45 codes, and Medicare paid $166K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,069 | 141 | $12.75 | $26K |
| 99213 Office E&M - Established | Office | 1,707 | 139 | $55.83 | $95K |
| 99211 Office E&M - Established | Office | 345 | 107 | $7.39 | $2,550 |
| 99212 Office E&M - Established | Office | 330 | 96 | $27.55 | $9,092 |
| 99484 Behavioral Health Services | Office | 137 | 28 | $44.14 | $6,047 |
| 96372 Injection Administration | Office | 126 | 43 | $11.46 | $1,444 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 105 | 13 | $0.54 | $56.3 |
| 93000 Electrocardiogram | Office | 81 | 67 | $10.24 | $829 |
| 99214 Office E&M - Established | Office | 50 | 33 | $102.14 | $5,107 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 48 | 48 | $132.56 | $6,363 |
| 96127 Behavioral Health Services | Office | 43 | 32 | $3.60 | $155 |
| G0008 Administration of influenza virus vaccine | Office | 40 | 37 | $33.10 | $1,324 |
| 90662 Vaccine Product | Office | 37 | 34 | $79.30 | $2,934 |
| 99203 Office E&M - New | Office | 15 | 15 | $76.10 | $1,141 |
By year: 2022 $102K for 2,165 services; 2023 $144K for 3,853 services; 2024 $166K for 7,052 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 40 | 37 | $3.89 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Mansukh R Ghadiya prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,092 prescriptions and refills. In total Mansukh R Ghadiya wrote 15,749 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,092 | 1,683 | 196 | $4,894 |
| Meloxicam Generic | 646 | 681 | 133 | $1,343 |
| Lisinopril Generic | 470 | 783 | 88 | $1,683 |
| Metformin Hcl Generic | 450 | 711 | 94 | $1,804 |
| Amlodipine Besylate Generic | 400 | 739 | 83 | $1,129 |
| Ezetimibe Generic | 348 | 495 | 68 | $3,942 |
| Baclofen Generic | 347 | 380 | 87 | $1,482 |
| Ketoconazole Generic | 333 | 349 | 53 | $14K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 318 | 319 | 51 | $3,555 |
| Omeprazole Generic | 305 | 433 | 65 | $1,323 |
| Furosemide Generic | 303 | 346 | 53 | $644 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 299 | 308 | 51 | $9,175 |
| Farxiga Dapagliflozin Propanediol | 278 | 322 | 40 | $174K |
| Allopurinol Generic | 273 | 323 | 41 | $889 |
| Gabapentin Generic | 266 | 306 | 54 | $1,742 |
Brand drugs: 2,379 claims; generic drugs: 13,250 claims; opioid claims: 464.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mansukh R Ghadiya $2,326 ($2,326 in general payments such as food, travel and fees) from 13 companies. The largest payer was Corcept Therapeutics with $775.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 18 | $775 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $349 |
| Xeris Pharmaceuticals, Inc. | 7 | $262 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $221 |
| Lilly USA, LLC LLY | 3 | $161 |
| GlaxoSmithKline, LLC. GSK | 4 | $150 |
| Amgen Inc. AMGN | 5 | $136 |
| Medtronic, Inc. MDT | 1 | $97.56 |
| Recordati_rare_diseases_inc. | 3 | $72.82 |
| Pfizer Inc. PFE | 2 | $53.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.